Information
-
Trademark
-
79254927
-
Serial Number
79254927
-
Registration Number
5887785
-
International Classifications
-
Filing Date
September 24, 2018
6 years ago
-
Registration Date
October 22, 2019
5 years ago
-
Transaction Date
November 22, 2024
6 months ago
-
Status Date
October 22, 2019
5 years ago
-
Published for Opposition Date
August 06, 2019
5 years ago
-
Location Date
October 22, 2019
5 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
HUSSAIN, TASNEEM
-
Law Office Assigned Location Code
M90
-
Owners
Mark Drawing Code
4
Mark Identification
TYGERA PHARMA
Case File Statements
- GS0051: Pharmaceutical preparations and substances, namely, pharmaceutical preparations and substances for use in hematology, oncology and for the treatment of cancer; reagents for medical use; medical diagnostic chemicals and medical diagnostic reagents for medical use; antibody-based chemicals and reagents for medical use, namely, monoclonal antibodies, immuno-radiotherapies, antibody-radionuclide-conjugates; radiotherapies in the nature of chemotherapeutics that have a similar mechanism of action; diagnostic assay test kits for medical use consisting of medical diagnostic chemicals and reagents; biochemical preparations, namely, antibodies for medical diagnostic and therapeutic use
- GS0441: Medical services; medical services in the field of healing, in particular diagnostic services in the field of hematology, oncology and the treatment of cancer; medical services, namely, immuno-radiotherapies and radiotherapies in the field of hematology, oncology and the treatment of cancer
- DS0000: "PHARMA"
- GS0421: Medical and pharmaceutical research and development, namely, medical and pharmaceutical research and development in the field of hematology, oncology and the treatment of cancer; conducting clinical trials for others, namely, conducting clinical trials in the field of hematology, oncology and the treatment of cancer; providing medical research and scientific research information, namely, in the field of hematology, oncology and the treatment of cancer
Case File Event Statements
-
4/2/2019 - 6 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/21/2019 - 6 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR
-
3/25/2019 - 6 years ago
2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED
Type: LIMI
-
4/2/2019 - 6 years ago
3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
4/5/2019 - 6 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/6/2019 - 6 years ago
6 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
4/6/2019 - 6 years ago
7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
4/29/2019 - 6 years ago
8 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
4/29/2019 - 6 years ago
9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
5/18/2019 - 6 years ago
10 - REFUSAL PROCESSED BY IB
Type: RFNT
-
6/18/2019 - 5 years ago
11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
6/18/2019 - 5 years ago
12 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
6/18/2019 - 5 years ago
13 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
6/20/2019 - 5 years ago
14 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
7/1/2019 - 5 years ago
15 - ASSIGNED TO LIE
Type: ALIE
-
7/17/2019 - 5 years ago
16 - NOTICE OF PUBLICATION
Type: NPUB
-
2/15/2020 - 5 years ago
20 - GENERIC MADRID TRANSACTION CREATED
Type: XXCR
-
8/6/2019 - 5 years ago
17 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
10/22/2019 - 5 years ago
18 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
1/22/2020 - 5 years ago
19 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
11/22/2024 - 6 months ago
23 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
3/13/2020 - 5 years ago
22 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINV
-
2/15/2020 - 5 years ago
21 - GENERIC MADRID TRANSACTION SENT TO IB
Type: XXSS